Zenotech Laboratories

Zenotech Laboratories Debt Growth

The Year-over-Year Debt Growth of Zenotech Laboratories (532039.BO) as of Nov 22, 2026 is -100.00 %. In the previous year, Year-over-Year Debt Growth was -70.95 % — a change of 40.94% (lower).

Debt Growth

-100.00 %

YoY

40.94%

Last updated:

Year-over-Year Debt Growth of Zenotech Laboratories is 2023 -100.00 % . Year-over-Year Debt Growth of Zenotech Laboratories was 2022 -70.95 % . It decreases by 40.94% lower compared to the previous year.

The Zenotech Laboratories Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2015
15.65 INR
Jan 1, 2016
-5.79 INR
Jan 1, 2017
-0.02 INR
Jan 1, 2018
-100.00 INR
Jan 1, 2020
-7.83 INR
Jan 1, 2021
10.72 INR
Jan 1, 2022
-70.95 INR
Jan 1, 2023
-100.00 INR
The Zenotech Laboratories Debt Growth history
YEARDebt GrowthYoY
-100.00 %+40.94%
-70.95 %-761.86%
10.72 %-237.00%
-7.83 %-92.17%
-100.00 %+492,307.69%
-0.02 %-99.65%
-5.79 %-137.01%
15.65 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Year-over-Year Debt Growth of Zenotech Laboratories is -100.00 % in 2023.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's Zenotech Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories